Daejeon, South Korea

Yong-Kook Kwon


Average Co-Inventor Count = 14.0

ph-index = 7

Forward Citations = 457(Granted Patents)


Company Filing History:


Years Active: 1998-2003

Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovations of Yong-Kook Kwon

Introduction

Yong-Kook Kwon is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biomedical research, particularly in the area of treating elevated blood lipid levels. With a total of 11 patents to his name, Kwon's work has the potential to impact public health positively.

Latest Patents

Among his latest patents is a method for preventing or treating elevated blood lipid level-related diseases by administering rutin and quercetin. This innovative approach involves administering an effective amount of these compounds to mammals, aiming to treat or prevent related diseases. His research focuses on the therapeutic benefits of these natural substances, showcasing his commitment to advancing medical science.

Career Highlights

Kwon has worked with esteemed institutions such as the Korea Institute of Science and Technology and the Korea Research Institute of Bioscience and Biotechnology. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to his success as an inventor.

Collaborations

Some of his notable coworkers include Song-Hae Bok and Tae-Sook Jeong. Their collaboration has likely fostered a productive environment for research and development, enhancing the quality of their collective work.

Conclusion

Yong-Kook Kwon's contributions to the field of biomedical research through his patents and collaborations highlight his role as a significant inventor. His innovative methods for treating elevated blood lipid levels demonstrate the potential for natural compounds in medical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…